Research To Practice | Oncology Videos Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates
Apr 8, 2025
54:56
Featuring an interview with Dr Adrienne G Waks, including the following topics:
- The Phase III AFT-38 PATINA trial of palbociclib combined with anti-HER2 therapy for hormone receptor (HR)-positive/HER2-positive metastatic breast cancer (mBC) (0:00)
- Role of immunotherapy in the treatment of breast cancer (8:30)
- Defining ER-low breast cancer and identifying treatment approaches for this histologic subtype (15:55)
- Genomic testing approaches for patients with localized breast cancer and identification of candidates for treatment with adjuvant olaparib (19:37)
- Current role of anthracyclines in the treatment of localized breast cancer (31:17)
- Available and novel antibody-drug conjugates for the treatment of breast cancer (41:21)
- Palbociclib with endocrine therapy compared to chemotherapy induction followed by endocrine therapy maintenance for HR-positive, HER2-negative mBC (51:53)